Lv et al. discovered that highly expressed ZEB1-AS1 in colorectal cancer may directly target and limit the production of miR-181a-5p, which results in increased levels of β-catenin and the transcription factor TCF4 which facilitate the development of CRC [22]. This evidence concerns the gene ZEB1 and colorectal carcinoma.